Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis THC Improve Oxygen Saturation During Sleep in Sleep Apnoea? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Sleep apnoea  often causes repeated drops in blood oxygen levels during the night. Researchers are exploring whether THC for oxygen saturation can stabilise oxygen levels and enhance overall sleep quality in affected individuals. 

Am I eligible for medical cannabis for pain relief?

Nocturnal Oxygen Monitoring 

Studies suggest that THC for oxygen saturation may influence respiratory patterns during sleep, potentially improving nocturnal oxygen with THC and reducing hypoxic episodes. 

SpO2 Stabilisation 

Evidence indicates that SpO2 with cannabis could remain more consistent, reducing abrupt desaturations that contribute to daytime fatigue and cardiovascular strain in sleep apnoea patients. 

Mechanism of Action 

THC for oxygen saturation is believed to modulate central respiratory control and pharyngeal muscle tone, supporting more stable airflow and oxygen delivery throughout the night. 

Potential Therapeutic Benefit 

By improving nocturnal oxygen with THC, patients may experience fewer interruptions in sleep, improved alertness during the day, and decreased risk of comorbidities associated with chronic hypoxia. 

Early research indicates that THC for oxygen saturation shows potential to enhance SpO2 with cannabis during sleep. While promising, further clinical trials are required to determine optimal dosing, safety, and long-term effects for managing sleep apnoea. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories